Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, B-Cell × Pharmacogenomic Variants × Clear all

Sponsor

Conditions

Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Glioma 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Ependymoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Adrenal Cortex Neoplasms 1

Interventions

Rituximab 34 Cyclophosphamide 24 Etoposide 12 Doxorubicin 12 Vincristine 11 Prednisone 11 ibrutinib 9 fludarabine 8 fludarabine phosphate 7 Mycophenolic Acid 5 Inotuzumab Ozogamicin 5 Cytarabine 5 pembrolizumab 4 Peripheral Blood Stem Cell Transplantation 4 Lenalidomide 4 Carmustine 4 CT-P10 4 Brentuximab Vedotin 4 Bortezomib 4 tositumomab I-131 3 tazemetostat 3 obinutuzumab 3 Prednisolone 3 Methylprednisolone 3 Melphalan 3 Ifosfamide 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Diphenhydramine 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡